» Articles » PMID: 22134354

MiR-34 and SNAIL Form a Double-negative Feedback Loop to Regulate Epithelial-mesenchymal Transitions

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2011 Dec 3
PMID 22134354
Citations 316
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, the inhibition of epithelial-mesenchymal-transition (EMT) by p53 has been described as a new mode of tumor suppression which presumably prevents metastasis. Here we report that activation of p53 down-regulates the EMT-inducing transcription factor SNAIL via induction of the miR-34a/b/c genes. Suppression of miR-34a/b/c caused up-regulation of SNAIL and cells displayed EMT markers and related features, as enhanced migration and invasion.  Ectopic miR-34a induced mesenchymal-epithelial-transition (MET) and down-regulation of SNAIL, which was mediated by a conserved miR-34a/b/c seed-matching sequence in the SNAIL 3'-UTR. miR-34a also down-regulated SLUG and ZEB1, as well as the stemness factors BMI1, CD44, CD133, OLFM4 and c-MYC. Conversely, the transcription factors SNAIL and ZEB1 bound to E-boxes in the miR-34a/b/c promoters, thereby repressing miR-34a and miR-34b/c expression. Since ectopic miR-34a prevented TGF-β-induced EMT, the repression of miR-34 genes by SNAIL and related factors is part of the EMT program. In conclusion, the frequent inactivation of p53 and/or miR-34a/b/c found in cancer may shift the equilibrium of these reciprocal regulations towards the mesenchymal state and thereby lock cells in a metastatic state.

Citing Articles

The Role of Epithelial-Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy.

Patrascu A, Tarca E, Lozneanu L, Ungureanu C, Morosan E, Parteni D Diagnostics (Basel). 2025; 15(5).

PMID: 40075892 PMC: 11898898. DOI: 10.3390/diagnostics15050644.


Gene regulatory network inference during cell fate decisions by perturbation strategies.

Hu Q, Lu X, Xue Z, Wang R NPJ Syst Biol Appl. 2025; 11(1):23.

PMID: 40032872 PMC: 11876352. DOI: 10.1038/s41540-025-00504-2.


Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.

Sravani A, Thomas J Heliyon. 2025; 11(3):e41964.

PMID: 39959483 PMC: 11830326. DOI: 10.1016/j.heliyon.2025.e41964.


Plasma microRNAs as Biomarkers for Predicting Radiotherapy Treatment-Induced Cardiotoxicity in Lung Cancer.

Kazlauskaite P, Vaicekauskaite I, Venius J, Sabaliauskaite R, Steponaviciene R Life (Basel). 2025; 14(12.

PMID: 39768327 PMC: 11679788. DOI: 10.3390/life14121619.


Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review.

Colin Waldo M, Quintero-Millan X, Negrete-Garcia M, Ruiz V, Sommer B, Romero-Rodriguez D Curr Issues Mol Biol. 2024; 46(12):13746-13766.

PMID: 39727949 PMC: 11674445. DOI: 10.3390/cimb46120821.